Name | Integrase-LEDGF/p75 allosteric inhibitor 1 |
---|
Description | Integrase-LEDGF/p75 allosteric inhibitor 1 (Compound 31h) is an orally active integrase-LEDGF/p75 (IN-LEDGF/p75) allosteric inhibitor. Integrase-LEDGF/p75 allosteric inhibitor 1 inhibits HIV-1 DNA integration and shows antiviral activity with an EC50 of 3.9 nM against HIV-1 recombinant molecular clone NL432[1]. |
---|---|
Related Catalog | |
Target |
EC50: 3.9 nM (NL432)[1] |
In Vivo | Integrase-LEDGF/p75 allosteric inhibitor 1 (Compound 31h) has moderate metabolic stability (HLM MS = 59%, RLM MS = 61%), exhibits good clearance (CLt = 6.99 mL/min/kg) and good bioavailability (F = 36%) in rats[1]. |
References |
Molecular Formula | C33H41NO6S |
---|---|
Molecular Weight | 579.75 |